Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stephan Kaun"'
Autor:
Katja Krüger, Martin Wichmann, Razif Gabdoulline, Katharina Götze, Krischan Braitsch, Franziska Modemann, Walter Fiedler, Arne Trummer, Jürgen Krauter, Stephan Kaun, Susanne Rotermund, Andreas Voß, Gudrun Goehring, Yvonne Behrens, Felicitas Thol, Matthias Eder, Gernot Beutel, Michael Stadler, Michael Heuser, Rabia Shahswar
Publikováno v:
HemaSphere, Vol 7, p e19815ef (2023)
Externí odkaz:
https://doaj.org/article/f4ec097299c942ab8ecfc9000edf757a
Autor:
Stefan Habringer, Uta Demel, Anne-Katrin Fietz, Felicitas Lammer, Roland Schroers, Silvia Hofer, Osnat Bairey, Jan Braess, Anna Sofia Meier-Stiegen, Reingard Stuhlmann, Martin Schmidt-Hieber, Johannes Hoffmann, Bettina Zinngrebe, Ulrich Kaiser, Peter Reimer, Robert Möhle, Peter Fix, Heinz-Gert Höffkes, Ulrich Langenkamp, Christian Meyer Zum Büschenfelde, Olaf Hopfer, Andrea Stoltefuß, Paul La Rosée, Henning Blasberg, Karin Jordan, Stephan Kaun, Meike Unteroberdörster, Ann-Christin von Brünneck, David Capper, Frank L. Heppner, Björn Chapuy, Martin Janz, Stefan Schwartz, Frank Konietschke, Peter Vajkoczy, Agnieszka Korfel, Ulrich Keller
Publikováno v:
HemaSphere, Vol 7, p e23520df (2023)
Externí odkaz:
https://doaj.org/article/d67d23a0e17241f095d53631b5f4bf8c
Autor:
Elisabeth Schorb, Benjamin Kasenda, Johannes Atta, Stephan Kaun, Anke Morgner, Georg Hess, Thomas Elter, Nikolas von Bubnoff, Martin Dreyling, Mark Ringhoffer, Stefan W. Krause, Günter Derigs, Beate Klimm, D. Niemann, Kristina Fritsch, Jürgen Finke, Gerald Illerhaus
Publikováno v:
Haematologica, Vol 98, Iss 5 (2013)
High-dose chemotherapy followed by autologous stem cell transplantation has been shown to be feasible and highly effective in newly diagnosed primary central nervous system lymphoma. In this retrospective multicenter study, we investigated prognosis
Externí odkaz:
https://doaj.org/article/7c9b5dcb86444f11bffc7618729dc3c3
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 145(4)
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 145:221-222
Autor:
Johannes Atta, Thomas Elter, Stephan Kaun, Dirk Niemann, G Derigs, Mark Ringhoffer, Anke Morgner, Elisabeth Schorb, Gerald Illerhaus, Nikolas von Bubnoff, Beate Klimm, Kristina Fritsch, Jürgen Finke, Stefan W. Krause, Martin Dreyling, Georg Hess, Benjamin Kasenda
Publikováno v:
Haematologica. 98:765-770
High-dose chemotherapy followed by autologous stem cell transplantation has been shown to be feasible and highly effective in newly diagnosed primary central nervous system lymphoma. In this retrospective multicenter study, we investigated prognosis
Autor:
Eckhard Thiel, Stephan Kaun, Michael Weller, Alexander Röth, Robert Möhle, Michael Rauch, Philipp Kiewe, Patrick Roth, Agnieszka Korfel, H. A. Klasen, Peter Martus
To assess the outcome of elderly patients with primary CNS lymphoma (PCNSL) treated within the G-PCNSL-SG-1 trial.We reviewed response, toxicity, and survival of patients with PCNSL aged 70 or more enrolled in the G-PCNSL-SG-1 trial.A total of 126 of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e095a6a61a38c6ec11e806d8760e16
https://www.ncbi.nlm.nih.gov/pubmed/22895585
https://www.ncbi.nlm.nih.gov/pubmed/22895585
Autor:
Robert Moehle, Philipp Kiewe, H. A. Klasen, Peter Martus, Eckhard Thiel, Alexander Roeth, Michael Rauch, Stephan Kaun, Agnieszka Korfel, Michael Weller, Patrick Roth
Publikováno v:
Journal of Clinical Oncology. 30:2007-2007
2007 Background: Age is the most important therapy-independent prognostic factor in patients with primary central nervous system lymphoma (PCNSL). Here we aimed at providing an analysis of the impact of higher age on response to therapy, toxicity, an
Autor:
Ingo G.H. Schmidt-Wolf, Mathias Schmid, Hartmut Döhner, Albrecht Reichle, E. Thiel, Nicola Gökbuget, Jan Walewski, Sebastian Irmer, Wolfgang Hiddemann, Michael Kneba, Martin-Leo Hansmann, Rainer Fietkau, Anita Baumann, Andreas Hüttmann, Dieter Hoelzer, Ulrich Dührsen, Stephan Kaun
Publikováno v:
Blood. 110:518-518
With short intensive chemotherapy mainly based on HDMTX, fractionated alkylators and HDAC outcome of Burkitt’s NHL and mature B-ALL (B-ALL) in adults could be improved substantially to CR rates of 80% and overall survival (OS) of 50–70% (Hoelzer
Autor:
Schorb, Elisabeth *, Kasenda, Benjamin *, Atta, Johannes *, von Bubnoff, Nikolas *, Elter, Thomas *, Hess, Georg *, Krause, Stefan W. *, Morgner, Anke *, Stephan, Kaun *, Fritsch, Kristina *, Finke, Jürgen, Illerhaus, Gerald *
Publikováno v:
In Blood 18 November 2011 118(21):3089-3089